Helge Ræder, PhD – Principal Investigator
For more than 13 years I have been working to become an international expert in translational medicine combining a career in clinical medicine (Pediatric Endocrinology) and basic science (molecular genetics, cellular physiology and proteomics). The results of my research have been published in a considerable number of high-impact journals; I won several junior international and national prizes for exceptional scientific achievements and hold one patent. During the course of my career, I established several international collaborations with experts in the field of diabetes. At the end of my PhD in 2005, I stayed 10 months in the lab of Prof Ron Kahn (several publications in Nature and Cell on insulin signaling; two collaborative papers) at Joslin Diabetes Center of Harvard Medical School, and established two mouse models of CEL-MODY. During my postdoctoral research stay 2010-11 as a Fulbright Visiting Scholar in the lab of Prof. Kulkarni (several publications in Nature, Science and Cell on beta cell physiology; four collaborative papers) at Joslin Diabetes Center of Harvard Medical School from 2010-2011, I continued to work on the mouse model of CEL-MODY. Furthermore, with my collaborator Prof Steve Gygi (five publications in Cell, Science and Nature since 2012 on topics related to proteomics; two collaborative papers) at the Department of Cell Biology at Harvard Medical School I used a proteome-wide approach to study protein abundance in the pancreatic juice of CEL-MODY patients in order to identify protein markers of disease progression towards diabetes (Raeder et al, 2014 and Bjørlykke et al, 2014). As the Principal Investigator I established a Norwegian biobank with secretin-stimulated duodenal juice and established, as senior investigator, a method to measure pancreatic output using secretin-stimulated duodenal juice (Tjora et al, 2013). Also as the Principal Investigator I established a biobank with fibroblasts from Norwegian MODY patients, and with colleagues at Joslin Diabetes Center and as senior investigator I successfully transformed these fibroblasts into induced pluripotent stem cells (Teo et al, 2013).
Therese Visted, MD, PhD
therese.visted [at] helse-bergen.no | ResearchGate |
Therese Visted finished Medical School in 1998 and received her PhD degree at the Department of Anatomy and Cell Biology in 2002, at the University in Bergen. She was a postdoctoral fellow in the lab of Prof. Chiocca at Massachusetts General Hospital, Harvard Medical School, USA 2002-2004. In 2014 she received her specialisation in paediatrics. Her scientific focus has been experimental therapy/cell biology, working on different models for delivery of biologically active agents (gene therapy, cell encapsulation).
Luiza Ghila, PhD
Luiza Ghila received a PhD in Neurobiology from University of Geneva, Switzerland. She was a postdoctoral fellow in the lab of Prof. Pedro Herrera at University of Geneva, Switzerland, working mainly on pancreatic islet cell plasticity and factors influencing alpha-to-beta cell transdifferentiation upon massive beta-cell loss.
Marc Vaudel, PhD
Marc Vaudel was a Ph.D. student at the Leibniz Institute for Analytical Science (ISAS), in the Proteomics Bioanalytics group. Marc obtained a PhD in biomedical sciences from the Ghent University in December 2012, and now works as a postdoc at the Department of Biomedicine of the University of Bergen.
Anne-Mette Søviknes, PhD
anne.soviknes [at]gmail.com | ResearchGate |
Anne-Mette Søviknes graduated cand. scient from molecular biological institute at the University of Bergen in 2000 and has completed her doctorate at the Sars Centre for Marine Molecular Biology of the University of Bergen in 2007. She was a postdoctoral fellow in the lab of Joel Glover at the University of Oslo.
Heidrun Vethe – PhD Candidate
heidrun.vethe [at] uib.no | ResearchGate |
Heidrun Vethe obtained her Master degree in Cell Biology from the Department of Biomedicine at the University of Bergen, Norway. She recently returned from a research stay at Joslin Diabetes Center, Harvard Medical School in Boston, USA.
Yngvild Bjørlykke – PhD Candidate
yngvild.bjorlykke [at] uib.no | ResearchGate |
Yngvild Bjørlykke has obtained her Master degree in Medical Cell biology from the Department of Biomedicine at the University of Bergen, Norway. She enrolled as a PhD-student in February 2015.
Anne Knudsen – Staff Engineer
Simona Chera, PhD
Simona Chera received a PhD in Regeneration and Developmental Biology from University of Geneva, Switzerland, and a B.Sc. in Genetics and Developmental Biology from University of Bucharest, Romania. She did a postdoc in the lab of Prof. Pedro Herrera at University of Geneva, Switzerland, where she mainly focused on the role of age in beta-cell regeneration and pancreatic islet cell plasticity. Simona holds now an Associate Professor position at Department of Clinical Science.
Harald Barsnes, PhD
harald.barsnes [at] uib.no | ResearchGate |
Harald Barsnes obtained his Master and PhD degrees at the Department of Informatics at the University of Bergen, Norway. Now Harald Barsnes is a group leader at both the Proteomics Unit (PROBE) at the Department of Biomedicine and at the Computational Biology Unit (CBU) at the Department of Informatics.
Constantin Berger – ERASMUS student
Constantin Berger obtained his Bachelor at the Julius-Maximilians Universitity in Wuerzburg, where he worked on the differentiation of mESC to intestine cells (title: “Time-dependent characterization of intestine cells derived from murine embryonic stem cells in vitro”). Between July-October 2015, he was an ERASMUS fellow in our lab working on differentiating iPSC on different decellularized matrices. Currently, Constantin is enrolled to the master program “Biomedical Science” at the Julius-Maximilians Universitity in Wuerzburg (due date September 2016).